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Summary: In extension of two previous series of experiments, the results of which have been partially reported (1),
further long-term tests were performed with daily oral doses of 5 mg Pb++ in 2 subjects. Lead in whole blood, free
protoporphyrin 9 (III) and 5-aminolevulinate dehydratase activity in erythrocytes, hemoglobin, and urinary 5-
aminolevulinic acid and coproporphyrin III excretion values were measured.
From experiences with 8 human experiments, three compartmental phases of early detectable lead effect were
postulated: 1. an "erythrocytic" reaction of 5-aminolevulinate dehydratase activity, 2. "hepatic" reactions of 5-
aminolevulinic acid and coproporphyrin, and 3. an "erythropoietic" reaction of protoporphyrin.
Langzeitbeobachtung biochemischer Bleiwirkungen bei Versuchen am Menschen
Zusammenfassung: In Fortsetzung zweier vorausgegangener Versuchsreihen, deren Ergebnisse teilweise früher ver-
öffentlicht worden sind (1), wurden weitere Langzeitstudien mit oralen Tagesdosen von 5 mg Pb++ bei 2 Versuchs-
personen durchgeführt. Sie umfaßten zeitlich dichte Verlaufskontrollen der Werte für Blei im Vollblut, freies Proto-
porphyrin 9 (III) und 5-Aminolävulinätdehydratase-Aktivität in den Erythrocyten, Hämoglobin und 5-Aminolävu-
linsäure- sowie Koproporphyrin HI-Ausscheidung im Urin.
Schlüsse aus den Erfahrungen an insgesamt 8 Versuchen führten zur Aufstellung der Hypothese, daß bei den früh
nachweisbaren Bleiwirkungeii drei kompartimentbezogene Phasen zu unterscheiden sind: 1. eine "erythrocytäre"
Reaktion der 5-Aminolävulinatdehydratase-Aktivität, 2. eine "hepatische" Reaktion von 5-Aminolävulinsäure und
Koproporphyrin, und 3. eine "erythropoetische" Protoporphyrin-Reaktion.
Introduction 3. the constancy of the response, or the extent to which
_ . * r i r * · · * t*16 measured response is indicative of dosageTo estimate the usefulness of a toxicological parameter r
for preventive purposes, including the control of workers a) ta every case of application of a certain poisonous
exposed to lead, one may start from the following substance, and
criteria· ^) during the whole duration of this influence;
4. the persistence of the response, to be judged from the
1. the specifity, i.e. the degree of exclusiveness in which interval between the end of the admission of the
the chosen parameter responds to the poison under poison and the definite normalization of the respective
consideration; parameter.
2. its sensitivity with regard to .
" " , .
 t. · · · - . t r xu These criteria cannot be determined satisfactorily by
a) the tune lag between the start of uptake of the
 mtm Qf $ ^  mtermittent ^ ,.
poison and its deteiminablhty, « i* exposure at the working site. Conditions must permit
b) the relation between a given dose of the poison and ^ ^ ^
 rf ^ ^ .^  rf ^
the magnitude of the response;
 and ^  ^ ^ rf do$es must ^ ^ unequivocal
responses of the parameters to be judged. The duration
, of the experiment, as well as the number and timing of
^ Data to a communication presented at the International ' f ' ,.
 A x A. ,. . xSymposium ^ Poiphyrias and Lead Intoxication, Marburg ** samples, must be subject to continuous adjustment,
1977 (J. Clin. Chem. Clin. Biochem./Vol. 16,1978/No. 1) depending on the progress of the whole investigation,
0340-076X/79/0225-0233S02.00
© by Walter de Gruyter & Co. · Berlin · New York
226 Schlegel and Kufner: Biochemical effects of lead in human experiments
and making allowance for unforeseen events. In short,
this is a situation which calls for self-experimentation.
In 1970, we carried out a first study on 2 subjects over
a period of 16 weeks, using daily oral doses of 1 mg
Pb++. In this preliminary test, apart from a slight in-
crease of protoporphyrin in both subjects (H.S. and
H.L.), none of the remaining parameters (hemoglobin,
5-aminolevulinic acid, coproporphyrin, and basophilic
punctated erythrocytes = "stippled cells") responded.
Therefore, the further choice of doses was made on the
basis of our experience over several years with numerous
industrial hygiene controls on clinically symptom-free
workers. We aimed at values clearly and repeatedly
above 153 μιηοΐ/ΐ 5-aminolevulinic acid, where we
could expect amounts of coproporphyrin above 0.9
μπιο1/1 and protoporphyrin above 1.78 μιηοΐ/l. In one
third of the cases, there could have been an increase of
stippled cells.
After an interval of 5 months, at the end of 1970 we
started a second series of experiments, in which a third
subject (G.K.) took part (1). Despite elevation of the
daily dose to 3 mg Pb++, this subject showed only a
slight rise of protoporphyrin near the end of the test,
which had been extended to 33 weeks, whereas the
remaining parameters did not respond. In the other
two subjects (H.S. and H.L.), however, this time there
was a marked response of 5-aminolevulinic acid, copro-
porphyrin, and protoporphyrin, beginning with the
third to fourth week of the administration of lead. As
to the sequence of their appearence there were no
significant differences, but the persistence of the proto-
porphyrin response considerably exceeded that of the
other parameters in both subjects. In none of the cases
was there an increase of stippled cells or a decrease of
hemoglobin. In a repetition of the same experiment 10
months later, subject H.L., who had shown a very
prompt response of 5-aminolevulinic acid and copro-
porphyrin, failed to respond with these parameters
altogether, whereas the protoporphyrin response took
place as before.
After completion of our preventive routine program for
lead-exposed personnel by the addition of values for
5-aminolevulinate dehydratase and blood lead in 1973,
we felt the need for further experiments, in order to
get as much information as possible about the relative
virtues of the different parameters according to the
above outlined postulates. Finally we intended to try
a contribution of our own towards the clarification of
some of the underlying biochemical processes.
Material and Methods
Subjects and exposure
Two male subjects, aged 61 and 36 years, respectively, and
occupationally not exposed to lead, received daily oral doses
of 5 mg Pb4"1" in the form of an aqueous solution of lead nitrate.
The administration lasted for 6 weeks in one person (H.S.) and
13 weeks in the other (O.K.). With regard to the different body
weights the daily exposure was 50 Mg/kg or 70 Mg/kg, which
resulted for the total experiment in 2.3 mg/kg and 6.5 mg/kg
respectively.
Urine and blood samples for determinations of 5-aminolevulinic
acid, coproporphyrin, protoporphyrin, blood lead, 5-amino-
levulinate dehydratase, and hemoglobin were collected in a
somewhat variable manner according to the aforementioned
principle. On the chosen days there was a sample of the first
urine voiding in the morning, with or without a simultaneous
venipuncture done somewhat later in the forenoon.
Laboratory methods
Determination of lead in blood
10 M! of a hemolyzed blood solution of heparin-stabilized
whole blood diluted with dest. water (1:6) was analyzed via
flameless atomic absorption. - Instruments: Perkin-Elmer
Model 300 with HGA 72 and D20-compensation. Wavelength:
283.3 nm. Molar coefficient of absorbance: e = 5.4 Χ 1041
• mof1 · cnf*.
Accuracy: precision in the series: CV = 2.6%
precision from day to day: CV = 6.1%
recovery of added lead: 97.5 ± 4.5%
Determination of free erythrocyte protoporphyrin, including
negligible amounts of coproporphyrin (2)
Accuracy: precision in the series: CV = 2.7%
precision from day to day: CV = 5.7%
recovery of added protoporphyrin: 99 ± 2%
Determination of 5-aminolevulinate dehydratase activity
The procedure is in accordance with the standardized method of
the European Community (3).
Accuracy: precision in the series: CV = 3.9%
precision from day to day: indeterminate due to
instability of the enzyme.
Determination of hemoglobin
Internationally standardized cyan-methemoglobin method.
Determination of 5-aminolevulinic acid in urine
The analytical procedures using thin-layer chromatography on
silica gel are described by Kufner & Schlegel (4).
Accuracy: precision in the series: CV = 1.1%
precision from day to day: CV = 2.4%
recovery of added 5-aminolevulinic acid: 99 ± 1.5%
Determination of coproporphyrin III in urine
10 ml urine of a fresh specimen, 6 ml sodium acetate (4.0 mol/1),
9 ml acetic acid cone. (5), and 30 ml diethyl ether are pipetted
into a translucent white closeable plastic bottle (volume 100 ml),
shaken vigorously, and exposed'to daylight (6) or to a 60 W
lamp respectively (minimum 3 h), to convert coproporphyrinogen
to coproporphyrin. After removing the urines-water layer and
washing with 10 ml dest. water, coproporphyrin III is analyzed
spectrophotometrically in accordance to procedures set forth
by Rimington (7).
Accuracy: precision in the series: CV = 1.9%
precision from day to day: CV = 4.8%
recovery of added coproporphyrin III: 96 ± 5%
Statistical evaluation
Statistical analysis served two purposes: 1. to observe the course
of each parameter, and 2. to demonstrate dependences between
blood lead and the other parameters as well as interdependences
between the latter.
1. Observation of the course of parameters. - For this, the
whole experiment was divided into 3 periods:
a) Preexposure period. - This served to ascertain for each
subject the normal range of the respective parameter. This
was based upon 5 analyses distribute^ over a fortnight.
An average value with variance was then calculated.
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b) Period of lead uptake. - During the first week daily blood
and urine samples were analyzed from Monday through
Friday: n = 5. During the following weeks of lead uptake,
samples were analyzed on Mondays, Tuesdays, and Fridays:
n = 3. For every week an average value and variance were
calculated.
c) Postexposure period. - During 11 weeks 3 weekly analyses
were maintained, followed by 2 analyses a week, until a
definite trend towards normalization of the parameters was
obvious; thereafter, analyses were performed once a week.
With n = 2, only mean values were calculated.
Following the preexposure period, the weekly average with its
corresponding variance was compared with the respective pre-
exposure value. Statistical judgement was carried out according
to the t-test (Student) for differences of means with hetero-
genous variance on the basis of small samples, because the F-test
had evidenced that the existing data were not homogenous.
There was a one-sided test with all parameters. For statistical
results see table 1.
2. Demonstration of dependences between blood lead and the
other parameters as well as interdependences between the latter.
To judge these criteria, the corresponding single analytical values
were consulted in each case. The recognized correlation was
calculated as function of regression and by means of the t-test
as coefficient of correlation (A. A. Fisher), and the statistical
security was characterized in the above-mentioned manner.
Results
Lead in whole blood
With subject H.S. (fig. 1), blood lead values rose as early
as the 1 st day after the onset of lead administration.
Significantly elevated values existed from the 1 st through
the 18th week; they appeared once more from the 20th
till the 26th week. A maximum of 3.09 (0.19)2) jumol/l
was reached in the 6th week. After termination of the
lead uptake, normalization of values took place rather
quickly during 10 weeks down to 1.58 (0.24) μτηοΐ/ΐ.
Definitively the preexposure level was reached after the
31st week (i.e. 25 weeks after the lead uptake had been
terminated.)
With subject G.K. (fig. 6), who extended the uptake of
lead to 13 weeks, blood lead values were significantly
elevated from the 2nd week and amounted to 1.45
(0.39) jLtmol/1 in the 6th week. By the 17th week, values
around 0.79 (0.25) μτηοΐ/ΐ fell within the normal range.
Free protoporphyrin 9 (HI) in erythrocytes
With subject H.S. (fig, 2), protoporphyrin values started
to rise significantly in the 3 rd week under lead influence.
Maximum values averageing 4.44 (0.14) μπιοΐ/ΐ were
attained not before the 19th week, i.e. 13 weeks after
cessation of lead uptake. Normalization, which
commenced afterwards, was nearly completed (0.68
μτηοΐ/ΐ) by the 46th week. For correlations with blood
lead and with other parameters see table 1.
With subject G.K. (fig. 6), the preexposure level was not
significantly exceeded until the 8th week; the rise of
protoporphyrin values was extremely slow. There was a
tendency to normalization 6 weeks after the lead uptake
had ended. No correlations whatsoever between proto-
porphyrin and the other parameters could be revealed in
this subject.
5'Aminolevulinate dehydratase activity in erythrocytes
With subject H.S. (fig. 3), significantly lowered values
were established from the 1 st till the 39th week. In this
experiment, maximum decrease of 5-aminolevulinate
dehydratase down to values about 7.13 U/l, i.e. less than
one third of the pre-exposure values, was attained during
the 5 th week. At the end of the 1 st week after the lead
uptake had been stopped, values started to rise again.
In the subject G.K. (fig. 6), as compaired with H.S.,
2) x ± s
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markedly milder response. Decrease of activity started
Tab. 1. Results of statistical evaluations.
Regression of parameters (Subject)
1. lead/protoporphyrin (H.S.)
2. 5-aminolevulinate-dehydratase/
protoporphyrin (H.S.)
3. lead/5-aminolevulinate-dehy-
dratase (H.S.)
4. lead/5-aminplevulinate-dehy-
diatase (H.S.)
5. lead/5 -aminolevulinate-dehy-
dratase (G.K.)
6. lead/5-aminolevulinate-dehy-
dratase (G.K.)
7. lead/5-aminolevulinic acid (H.S.)
8. lead/5-aminolevulinic acid (H.S.)
9. 5-arninolevulinic acid/copro^
porphyrin (H.S.)
10. lead/coprppprphyrin (H.S.)
11. lead/coprpporphyrin (H.S.)
Period
2. -7. week
19.^46. week
preexposure time and
1.-3. week
13.-46. week
preexposure time and
1.-8. week
9.— 12. week
preexposure time and
1. -7. week
7. -17. week
preexposure time and
1.- 17. week
preexposure time and
1.- 11 week
7.- 17. week
Equation of regression
y = 2.166 + 0.277 χ
y = e (0.822-1. 804 χ)
y -2,616- 0.060 χ
y = e (0.455 - 0.686 x)
y = 2,243 - 0,055 χ
y = 2,935 - 0.068 χ
y = -1.522 + In 0.917 χ
y = -0.1 12 + In 0.583 χ
y = 5.591 + 0.150 x
y = -2.775 + In 0.864
y = -2.007 + In 0.7 36 x
t
3.858
3.354
6.911
4.746
7.657
7.818
4.742
5.984
10.783
4.742
7.033
r
0.880***
-0.573***
-0.990***
-0.661***
-0,945***
-0,984***
0.888***
0.904***
0.945***
0.900***
0.928***
DF
14
29
14
45
27
10
23
27
52
23
27
Abbreviations: t = t (Student); r = coefficient of correlation; DF = degrees of freedom; r*** = p < 0.001
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5mg Pb** per os daily
0 2. 4. 6. 8. 10. 12. 14. 16. 18. 20. 22. 24. 26. 28. 30. 32. "31 36. 38. 40. 42. 44. 46. Week
Fig. 1. Course of changes of lead in whole blood in subject H.S., weekly means and standard deviations (χ ± Is).
5mg Pb** per os doily
0 2. 4. 6. 8. 10. 12. 14. 16. 18. 20. 22. 24. 26. 28. 30. 32. 34. 36. 38. 40. 42. 44. 46. Week
Fig. 2. Course of changes of free protopoiphyrin 9 (III) in erythrocytes in subject H.S., weekly means and standard deviations, com-
pared with changes of lead in whole blood.
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Fig. 3. Course of changes of 5-aminolevulinate dehydratase activity in erythrocytes in subject H.S., weekly means and standard
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0 2. 4. 6. 8. 10. Ϊ2. 14. 16. 18. 20. 22. 24. 26. ^28;"30."32."34. 36. 38: 40.' 42. "44. "46.Week
Fig. 5. Course of changes of urinary coproporphyrin-III in subject H.S., weekly means and standard deviations, compared with
changes of lead in whole blood.
with the onset of lead uptake and attained a minimum
of 14.6 (2.76) U/l during the 6th week. When the lead
uptake had been terminated at the end of the 13th week,
normalization took place up to 32.0 (2.10) U/l during
the following 10 weeks.
Hemoglobin
As in our previous tests using smaller doses of lead, there
was no noticeable response of hemoglobin values with
both subjects in the course of this experiment. Under
lead influence, values did not differ significantly from
those during the preexposure period. There were no
correlations with either blood lead or other parameters.
5-Aminolevulinic acid in urine
With subject H.S. (fig. 4), 5-aminolevulinic acid started
to rise in the 3rd week and attained a single maximum
value of 243.5 jumol/1 in the 6th week. Highly significant
elevations lasted from the 4th through 8th week. With
this parameter, decline to normal values began in the
very first week after cessation of lead uptake and was
completed in the 3rd week thereafter.
With subject G.K., 5-aminolevulinic acid values remained
unchanged throughout. There were no significant changes
relative to the incorporated amounts of lead; no correl-
ations existed with other parameters.
Coproporphyrin-III in urine
With subject H.S. (fig. 5), coproporphyrin started to
rise in the 3rd week and attained a single maximum
value of 1.3 μτηοΐ/ΐ in the 6th week. Values were signif-
icantly elevated from the 4th through the 9th week.
With this parameter, as with 5-aminolevulinic acid,
decline to normal values began in the first week after
cessation of lead uptake.
With subject G.K., coproporphyrin values also remained
unchanged; there were no correlations with blood lead
or with other parameters of effect.
Discussion
As could be expected, our data pertaining to the meas-
uring characteristics of the different parameters of lead
uptake and lead effect are essentially in accordance with
the findings oiStuik (8) and Cools et al. (9), who ex-
posed volunteers to smaller doses of orally given lead
for 3 weeks or 7 weeks, respectively, as well as with
those of Tola et al. (10) wdBenson et al. (11), who
examined workers undergoing occupational lead ex-
posure for the first time in their lives by way of longi-
tudinal surveys of 12 weeks or 4 months, respectively.
The authors stated that:
a) there is no time lag in the response of blood lead (8,
9,10, 11) or of 5-aminolevulinate dehydratase (8, 9,
10);
b) responses of heme precursors first appear within 2 to
3 weeks, s do the responses of protoporphyrin (8),
5-aminolevulinic acid (8,10,11), and coproporphyrin
(10,11);
c) there is a persistent rise of protoporphyrin values
(8,9);
s *
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Fig. 6. Course of changes of 5-aminolevulinate dehydratase activity in erythrocytes, free protoporphyrin 9 (HI) in erythrocytes, and
lead in whole blood in subject G.K., weekly means and standard deviations.
d) changes of 5-aminplevulinic acid and copropprphyrin
are more or less well related to each other, showing a
similar response pattern of these two paiameters (10,
n);
e) sensitivity of hemoglobin seemed to be very low to
nil in the experiments ofStuik (8) and Cools et al.
(9), whereas Tola et al: (10) recommonded observation
of the differences in serial estimations to establish
small changes as early indicators of lead anemia.
The most outstanding feature of our own series of ex-
periments was the confirmation of an obviously low
rate of enteral lead absorption in the subject G.K., as
had been observed in our previous experiment (1). We
must admit, however, that we cannot offer any clue to
J. Clin. Chem. Clin. Biochem, / Vol. 17,1979 / No. 4
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the explanation of this phenomenon. Dietary causes,
particularly high calcium intake, as well as disturbances
of gastrointestinal function, can be excluded. Interindi-
vidual differences in the susceptibility to lead poisoning
have been reported at all times, but to our knowledge
were never corroborated in long-term experiments.
To elucidate the question as to what mechanism is re-
sponsible for this interesting fact remains a toxicologi-
cal problem which cannot presumably be solved by
animal experiments alone.
To what extent can the usefulness of a given laboratory
parameter for preventive purposes in current industrial
hygiene be judged by the above criteria? On the basis of
our experimental results we come to the following con-
clusions:
1. Specifity has not been tested, since we did not apply
"other poisons besides lead. It may be worth mentioning,
however, that during our long-term experiments we
never got the impression that alcohol could exercise
an influence if taken within the limits of moderate
social drinking habits. In cases of high alcohol intake,
depression of 5-aminolevulinate dehydratase activity
(12) and augmented excretion of coproporphyrin, the
latter with respect to its significance as a possible
indicator of hepatic disorders (13), might be encount-
ered. From some rather sketchy experiences with
heavy drinking individuals, in accordance mihDoss
& Schmidt (14), we feel that 5-aminolevulinic acid
should also be included in this consideration.
2. Sensitivity
a) The time lag between the start of uptake of the
poison and the evidence of its presence or effects,
is shortest for blood lead and 5-aminolevulinate
dehydratase; there seems to be no appreciable time
lag at all for these two parameters. Concerning
blood lead, this should be a matter of analytical
precision alone. For 5-aminolevulinate dehydratase,
we assume an immediate and direct effect on the
enzyme contained in the circulating erythrocytes,
where it no longer serves any purpose in connection
with heme synthesis. We therefore designate this
first phase of lead effect as the "ery throcy tic
reaction".
Clearly separated from this are the responses of
protoporphyrin, 5-aminolevulinic acid, and copro-
porphyrin with a time lag of about 3 weeks. Of
these, the protoporphyrin response is characterized
by its prolonged rise to a peak, which usually comes
considerably after the termination of lead uptake.
Augmentation of free erythrocyte protoporphyrin
is brought about by inhibition of the enzyme ferro-
chelatase in the erythroblästs, which we call the
"erythropoietic reaction" to lead. The time
relations of this phenomenon are subject to the
maturation of red cells.
Increased excretion of 5-aminolevulinic acid and
coproporphyrin appears synchronously. Of these
heme precursors, the amounts lost via the urine in
some clinically symptom-free, non-anemic indi-
viduals may be so high that the bulk of their origin
must be localized in the liver. Therefore, we
propose to call this the "hepatic reaction" to lead
uptake.
b) With regard to the relation between the dose of
the poison and the magnitude of the response,
sensitivity is highest with 5-ammolevulinate
dehydratase and protoporphyrin, whereas the
"hepatic" parameters will not respond to low lead
uptake, hence their usefulness for deliminating
decisions in preventive industrial hygiene.
3. Constancy of response:
a) the reproducibility of the effect must be questioned
at least for 5-aminolevulinic acid and copropor^
phyrin, which failed to respond a second time with
subject H.L. in our previous experiment (1);
b) for the whole duration of lead influence there was
a remarkable lack of constancy concerning 5-amino-
levulinate dehydratase with subject G.K. in this
series of experiments. With 5-aminolevulinic acid
and coproporphyrin, there may be adaptation
mechanisms with prolonged uptake of moderate
amounts of lead.
4. Persistence of the response seems to be highest with
protoporphyrin, due to its medullary origin. In lead
anemia, a similar time lag should be expected for
hemoglobin as well. Persistence of 5-aminolevulinate
dehydratase inhibition was at least as high as the
continuance of elevated blood lead values in the scope
of our experiments. Moreover, we got the impression
that augmented protoporphyrin could possibly
exercise a feedback influence on 5-aminolevulinate
dehydratase activity. Though statistically we could
secure correlations between protoporphyrin and 5-
aminolevulinate dehydratase on the one hand
(table 1, No. 2), and between blood lead and 5-amino-
levulinate dehydratase on the other (table 1, No. 3),
we are not able to judge them for their pathogno-
monic conclusiveness, since both of them are known
(15,16) as inhibitors (protoporphyrin competitive,
blood lead non-competitive) of 5-aminolevulinate
dehydratase.
The most limited persistence exists in the "hepatic
reaction" of 5-aminolevulinic acid and coproporphyrin,
where the decline of values after termination of lead
uptake regularly showed a clearly steeper slope than
the gradient of increase under lead influence. We
attribute this to a sudden adjustment of lead level
in the portal venous blood to that of the systemic
circulation, when lead absorption via the enteral
pathway is interrupted.
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With respect to the relative virtues of the different
parameters concerning the early diagnosis of lead
poisoning, one cannot easily put up a sequence of
their validity, so as to single out the most suitable and
discard the rest of them.
At a screening stage, 5-aminolevulinate dehydratase
activity in blood and urinary excretions of 5-amino-
levulinic acid and coproporphyrin will answer the
question, as to whether a lead effect may exist at all
and what its magnitude might be. Because of their
limited lead specifity, repeatedly abnormal results of
the aforementioned parameters must be supported by
measurements of blood lead and protoporphyrin.
For preventive purposes, the hemoglobin value as well
as stippled cell count must be regarded as obsolete
because of their low sensitivity or manifestation rate,
respectively.
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